Vela Sentosa SA HSV1/2 Qualitative PCR Test
Devicemedical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test
Other names: Sentosa HSV Assay
NCT Number: NCT02685956
The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.
Looking for future studies?
Notify MeAll sexes
Observational
Tampa General Hospital, Tampa, Florida, United States
This study will utilize residual samples from male and female patients with signs and symptoms of oral or genital HSV infections. Genital samples will include internal and external genital lesions such as those collected from lesions of the anus, buttocks, vagina, labia, or penis. Oral samples will include those collected from lip, gum, and mouth lesions. For concordance testing, the sample size is based on historical study design and estimates of the expected prevalence of HSV1 and/or HSV2 in the population enrolled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test
Other names: Sentosa HSV Assay
Time frame: within 60 days of last sample enrollment
Study will assesses Sentosa HSV 1/2 assay fpr detecting HSV DNA compared to traditional microbiology culture-based ELVIS method (reference assay). HSV DNA detection is determined for each virus (HSV 1 and 2) at each type of anatomic site (genital lesion and oral lesion).
Time frame: within 60 days of last sample enrollment
Study asses Sentosa HSV 1/2 assay in detecting HSV DNA compared to traditional microbiology culture-based ELVIS method (reference assay). HSV DNA detection is determined for each virus (HSV 1 and 2) at each type of anatomic site (genital lesion and oral lesion).
Vela Diagnostics
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05468619
DNA Virus Infections, Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05298254
Communicable Diseases, DNA Virus Infections
Phoenix, Arizona, United States
View Trial DetailsNCT05989672
DNA Virus Infections, Herpes Simplex
Tokyo, Japan
View Trial DetailsNCT01959295
DNA Virus Infections, Herpes Simplex
Sapporo, Hokkaido, Japan
View Trial Details